logo
logo
Sign in

Erectile Dysfunction Drugs Market Is Hitting New Highs at 6.5% of CAGR to Reach USD 2.95 billion During 2018-2023

avatar
rahul kumar
Erectile Dysfunction Drugs Market Is Hitting New Highs at 6.5% of CAGR to Reach USD 2.95 billion During 2018-2023

Nov 20, 2018 (Heraldkeeper via COMTEX) -- The Market for Erectile Dysfunction Drugs is growing rapidly and expected to continue its growth in near future.

However, factors such as growing threat from counterfeit drugs, prevalence of STDs in erectile dysfunction drug users, and shrinking insurance coverage for ED treatment will hamper the growth of global erectile dysfunction market.

Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology.

In June 1, 2017, Pfizer Limited (India) acquired AstraZeneca's Neksium.

The company also has offices in Puerto Rico and 17 other countries.

The company manufactures a drug named Cialis for erectile dysfunction.

collect
0
avatar
rahul kumar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more